MetAP Antibodies

Santa Cruz Biotechnology features a diverse variety of MetAP Antibodies for investigating methionine aminopeptidases (MetAPs) in various biological processes. MetAP monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Methionine aminopeptidases catalyze the removal of N-terminal methionine from nascent proteins, a critical step in protein maturation and function. MetAPs are central to cellular processes, including protein synthesis, signal transduction, and cell cycle regulation. Research has shown MetAPs to be significant in various diseases, including cancer and cardiovascular disorders, making them important targets for therapeutic intervention and biomarker discovery. Understanding MetAP function and regulation continues to reveal new insights into cellular mechanisms and disease pathways. MetAP research advances our knowledge of protein processing and its impact on cellular health. Investigating MetAP activity helps identify potential therapeutic strategies for various medical conditions. Santa Cruz Biotechnology monoclonal antibodies for MetAP research support scientists in advancing our understanding of fundamental biological processes and disease mechanisms.